Literature DB >> 22261872

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors.

Massimo Falconi1, Detlef Klaus Bartsch, Barbro Eriksson, Günter Klöppel, José M Lopes, Juan M O'Connor, Ramón Salazar, Babs G Taal, Marie Pierre Vullierme, Dermot O'Toole.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22261872     DOI： 10.1159/000335587

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN： 0028-3835            Impact factor:   4.914


× No keyword cloud information.
  139 in total

Review 1.  Genetics of pancreatic neuroendocrine tumors: implications for the clinic.

Authors:  Antonio Pea; Ralph H Hruban; Laura D Wood
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-09-28       Impact factor: 3.869

2.  Feasibility of Radio-Guided Surgery with ⁶⁸Gallium-DOTATATE in Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumors.

Authors:  Samira M Sadowski; Corina Millo; Vladimir Neychev; Rachel Aufforth; Xavier Keutgen; Joanne Glanville; Meghna Alimchandani; Naris Nilubol; Peter Herscovitch; Martha Quezado; Electron Kebebew
Journal:  Ann Surg Oncol       Date:  2015-09-08       Impact factor: 5.344

3.  The use of targeted therapies in pancreatic neuroendocrine tumours: patient assessment, treatment administration, and management of adverse events.

Authors:  Meredith Cummins; Nick Pavlakis
Journal:  Ther Adv Med Oncol       Date:  2013-09       Impact factor: 8.168

Review 4.  Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives.

Authors:  Marco Gallo; Pasqualino Malandrino; Giuseppe Fanciulli; Francesca Rota; Antongiulio Faggiano; Annamaria Colao
Journal:  J Cancer Res Clin Oncol       Date:  2017-04-12       Impact factor: 4.553

Review 5.  [Classification and malignant potential of pancreatic cystic tumors].

Authors:  I Esposito; A M Schlitter; B Sipos; G Klöppel
Journal:  Pathologe       Date:  2015-02       Impact factor: 1.011

6.  Grading of EUS-FNA cytologic specimens from patients with pancreatic neuroendocrine neoplasms: it is time move to tissue core biopsy?

Authors:  Rakesh Vinayek; Gabriele Capurso; Alberto Larghi
Journal:  Gland Surg       Date:  2014-11

7.  Analysis of 100 consecutive cases of resectable pancreatic neuroendocrine neoplasms: clinicopathological characteristics and long-term outcomes.

Authors:  Yugang Cheng; Hanxiang Zhan; Lei Wang; Jianwei Xu; Guangyong Zhang; Zongli Zhang; Sanyuan Hu
Journal:  Front Med       Date:  2016-12-23       Impact factor: 4.592

Review 8.  Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances.

Authors:  Tetsuhide Ito; Hisato Igarashi; Robert T Jensen
Journal:  Best Pract Res Clin Gastroenterol       Date:  2012-12       Impact factor: 3.043

9.  Minimally Invasive Versus Open Pancreatic Surgery in Patients with Multiple Endocrine Neoplasia Type 1.

Authors:  Caroline L Lopez; Max B Albers; Carmen Bollmann; Jerena Manoharan; Jens Waldmann; Volker Fendrich; Detlef K Bartsch
Journal:  World J Surg       Date:  2016-07       Impact factor: 3.352

10.  Safety and QOL in Patients with Advanced NET in a Phase 3b Expanded Access Study of Everolimus.

Authors:  Marianne Pavel; Nicole Unger; Ivan Borbath; Sergio Ricci; Tsann-Long Hwang; Thomas Brechenmacher; Jinhee Park; Fabian Herbst; Jennifer L Beaumont; Oliver Bechter
Journal:  Target Oncol       Date:  2016-10       Impact factor: 4.493
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.